via Indiana University School of Medicine
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them—an insulin whose activity in the bloodstream responds to the blood glucose levels and adjusts accordingly?
An invention from Indiana University School of Medicine Distinguished Professor Michael A. Weiss, MD, PhD, could lead to just that.
In a breakthrough study published in the peer-reviewed journal PNAS, Weiss and his team describe the use of a synthetic “switch” that can be opened or closed using a simple sugar sensor. The study was in part collaborative with Thermalin, Inc., a small biotech company that Weiss began in 2008.
Their concept exploits a natural mechanism, designated the “protective hinge,” that is built into vertebrate insulins. The protective hinge is a natural structural feature that evolved more than half a billion years ago to keep the hormone stable in its closed state but foldable and functional in its open state.
“The reason a glucose-responsive insulin is important is that the biggest barrier to the effective use of insulin, especially in Type 1 diabetes, is the fear of the consequences of blood sugar going too low,” said Weiss, who is also the Chair of the Department of Biochemistry and Molecular Biology.
Immediate consequences of severely low blood sugar (hypoglycemia) can include delirium, convulsions or loss of consciousness, and repeated episodes of severe hypoglycemia can cause cognitive decline. On the other hand, chronic high blood sugar (hyperglycemia) can lead to blindness, stroke or amputation. Staying in the desired blood glucose range is a delicate balance that insulin-dependent diabetics face every day.
But Weiss said that he envisions a future when people do not have to choose to risk their long-term health to protect themselves from the immediate dangers of severe hypoglycemia.
“The promise of this kind of ‘smart’ insulin is that it would transform diabetes care, so people wouldn’t have to worry anymore,” said Weiss. “With our invention, we envision that when the blood sugar goes low, the hinge would close. But there will be much work to do to translate our proof of principle to an FDA-approved product.”
In the 100 years since the discovery of insulin, its use as a treatment for diabetes has gone through many significant changes. C. Ronald Kahn, MD, chief academic officer at the Joslin Diabetes Center at Harvard Medical School, said that glucose-responsive insulin could be the next.
“In the recent study from the Weiss laboratory appearing in PNAS, we see an example of the next exciting phase of insulin development, namely development of an insulin analogue which through chemical modification can sense the level of sugar present in the blood,” said Kahn. “While the current analogue has been designed to sense fructose, it seems likely that this same approach can be used to develop analogues to sense glucose. Whether these can be sensitive enough to be modulated by changes within the physiological range remains to be determined, but if so, this would be an important new tool in the management of diabetes.”
Other types of glucose-responsive insulins are being developed elsewhere. What makes Weiss’ invention unique is its simplicity. The synthetic hinge exploits naturally occurring processes and introduces fewer external or artificial elements compared to other approaches.
While their study uses fructose as model (representative of a monosaccharide like glucose), it proves that Weiss’ synthetic hinge concept works. His team is already working on glucose-responsive insulin candidates that open and close at the desired high and low glucose thresholds, which are respectively 70 to 180 milligrams per deciliter. By replacing the fructose sensor with glucose sensors, a revolutionary insulin therapy may be closer than we think.
Original Article: Synthetic hinge could hold key to revolutionary “smart” insulin therapy
More from: Indiana University School of Medicine | Indiana University | Case Western Reserve University | University of Melbourne
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Glucose-responsive insulin
- BRD7 research points to alternative insulin signaling pathway
Bromodomain-containing protein 7 (BRD7) was initially identified as a tumor suppressor, but further research has shown it has a broader role in other cellular processes, including the remodeling of ...
- The Interconnection Between Insulin Resistance and Cardiovascular Risk: Unveiling the Complex Relationship
In the intricate web of human physiology, the relationship between insulin resistance and cardiovascular risk stands as a critical nexus. As our understanding deepens, it becomes ...
- Top 8 Best Berberine Supplements for Insulin Resistance in 2024
While the Sotalix Berberine Supplement may help regulate blood sugar levels ... for managing insulin resistance vary depending on the individual’s health status and response to the supplement.
- 13 Ways to Lower Your Insulin Levels
Apple cider vinegar (ACV) may help prevent insulin and blood sugar spikes after eating ... of vinegar daily appears to improve glycemic response to carbohydrate-rich meals. It’s important ...
- Stress May Increase Your Risk of Insulin Resistance—Here's What Health Experts Say Can Help
Reviewed by Dietitian Maria Laura Haddad-Garcia You know what it feels like to have your stress spike. It’s an emotional and physical response. Your palms sweat before a big presentation. Your heart ...
Go deeper with Google Headlines on:
Glucose-responsive insulin
[google_news title=”” keyword=”glucose-responsive insulin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Smart insulin
- Mesa doctor says inhaled insulin being considered ‘standard of care’ expands patient access
Inhaled insulin is now included in the "standard of care" for diabetics, and a Mesa doctor says this will help many patients get insurance coverage for it.
- Scientists one step closer to breakthrough insulin pill
An estimated 75 million people worldwide inject themselves with insulin roughly 6-7 times a day. Now, researchers are using nanotechnology to create a pill form of the medication, which includes a ...
- Inhaled insulin could improve lives of patients with diabetes
However, recent innovations, such as inhaled insulin, the hormone made by the pancreas, which controls blood sugar, have sparked hope for more effective and user-friendly treatments. Diabetes is ...
- Insulin affordability impacts public health
More than 8 million Americans rely on insulin to survive, according to the American Diabetes Association, but with high prices and supply shortages hampering access, lawmakers and healthcare ...
- Insulin: How Does It Work?
Insulin is a hormone your body makes that helps it control your blood sugar level and metabolism — the process that turns the food you eat into energy. Your pancreas makes insulin and releases ...
Go deeper with Google Headlines on:
Smart insulin
[google_news title=”” keyword=”smart insulin” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]